HLA-C and neoplasm: Innate immunity mainly recognizes the absence of normal cell biomarkers through the ‘missing self’ effect while adaptive immunity mainly recognizes the appearance of abnormal tumor biomarkers by binding T cell receptors (TCRs) to antigenic peptide-MHC (pMHC) [68].